ADVERTISEMENT

Alexey Danilov, MD

Alexey Danilov, MD

Conference Coverage

Exciting Developments and Novel Targets in Chronic Lymphocytic Leukemia Treatment

10/21/2024

Alexey Danilov , MD;

Alexey Danilov, MD, reviews the latest exciting developments in the chronic lymphocytic leukemia clinical research landscape, highlighting BTK and BCL2 inhibitors as well as BTK degraders.

Alexey Danilov, MD, reviews the latest exciting developments in the chronic lymphocytic leukemia clinical research landscape, highlighting BTK and BCL2 inhibitors as well as BTK degraders.

Alexey Danilov, MD, reviews the...

10/21/2024

Oncology

Alexey Danilov, MD

Conference Coverage

Selecting Optimal Frontline Therapies for Treating Patients With CLL

10/21/2024

Alexey Danilov , MD;

At the 2024 Lymphoma, Leukemia & Myeloma Congress, Alexey Danilov, MD, participated in a debate of optimal frontline therapies for patients with chronic lymphocytic leukemia in which he argued in favor of utilizing acalabrutinib.

At the 2024 Lymphoma, Leukemia & Myeloma Congress, Alexey Danilov, MD, participated in a debate of optimal frontline therapies for patients with chronic lymphocytic leukemia in which he argued in favor of utilizing acalabrutinib.

At the 2024 Lymphoma, Leukemia &...

10/21/2024

Oncology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

October 26 ⁠–⁠ October 27

October 29 ⁠–⁠ November 2

November 1 ⁠–⁠ November 2

November 6 ⁠–⁠ November 8

NEI Congress

November 7 ⁠–⁠ November 10

WoundCon

November 8

November 8 ⁠–⁠ November 10

Dermatology Week

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

See Full Calendar

Advertisement

Advertisement